{"entity":{"type":"insider","cik":"0001763511","url":"/insider/0001763511","json_url":"/insider/0001763511.json","name":"Elsbernd Brian","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":8,"first":"2022-11-15","last":"2025-11-14","span_basis":"filed_date"},"name_variants":[{"name":"Elsbernd Brian","source":"filing","n_filings":8,"first_seen":"2022-11-15","last_seen":"2025-11-14"}],"transactions":[{"id":4031402,"accession":"0001161697-25-000374","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-25-000374","line_url":"/filing/0001161697-25-000374#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001763511","owner_name":"Elsbernd Brian","owner_display_name":"Elsbernd Brian","owner_url":"/insider/0001763511","role":"Officer (Chief Compliance/Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Compliance/Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Compliance/Legal Officer","security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":22.7,"price_display":"22.70","price_state":"stated","total_value":908000.0,"total_display":"908,000.00","total_whole":"908,000","shares_owned_after":231039.0,"shares_owned_after_display":"231,039","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-12","filed_date":"2025-11-14","scope":"insider"},{"id":4671782,"accession":"0001161697-25-000320","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-25-000320","line_url":"/filing/0001161697-25-000320#line-2","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001763511","owner_name":"Elsbernd Brian","owner_display_name":"Elsbernd Brian","owner_url":"/insider/0001763511","role":"Officer (Chief Compliance/Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Compliance/Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Compliance/Legal Officer","security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":20.3,"price_display":"20.30","price_state":"stated","total_value":609000.0,"total_display":"609,000.00","total_whole":"609,000","shares_owned_after":271039.0,"shares_owned_after_display":"271,039","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-08","filed_date":"2025-09-10","scope":"insider"},{"id":4754203,"accession":"0001161697-25-000318","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001161697-25-000318","line_url":"/filing/0001161697-25-000318#line-4","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001763511","owner_name":"Elsbernd Brian","owner_display_name":"Elsbernd Brian","owner_url":"/insider/0001763511","role":"Officer (Chief Compliance/Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Compliance/Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Compliance/Legal Officer","security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":19.52,"price_display":"19.52","price_state":"stated","total_value":585600.0,"total_display":"585,600.00","total_whole":"585,600","shares_owned_after":188564.0,"shares_owned_after_display":"188,564","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-04","filed_date":"2025-09-05","scope":"insider"},{"id":4754197,"accession":"0001161697-25-000318","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-25-000318","line_url":"/filing/0001161697-25-000318#line-2","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001763511","owner_name":"Elsbernd Brian","owner_display_name":"Elsbernd Brian","owner_url":"/insider/0001763511","role":"Officer (Chief Compliance/Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Compliance/Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Compliance/Legal Officer","security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":20.08,"price_display":"20.08","price_state":"stated","total_value":401600.0,"total_display":"401,600.00","total_whole":"401,600","shares_owned_after":188564.0,"shares_owned_after_display":"188,564","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-03","filed_date":"2025-09-05","scope":"insider"},{"id":4170764,"accession":"0001161697-25-000085","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001161697-25-000085","line_url":"/filing/0001161697-25-000085","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001763511","owner_name":"Elsbernd Brian","owner_display_name":"Elsbernd Brian","owner_url":"/insider/0001763511","role":"Officer (Chief Compliance/Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Compliance/Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Compliance/Legal Officer","security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":62975.0,"shares_display":"62,975","price_per_share":22.976304088924177,"price_display":"22.98","price_state":"stated","total_value":1446932.75,"total_display":"1,446,932.75","total_whole":"1,446,933","shares_owned_after":188564.0,"shares_owned_after_display":"188,564","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-05","scope":"insider","n_lines":2},{"id":2247630,"accession":"0001161697-24-000490","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001161697-24-000490","line_url":"/filing/0001161697-24-000490","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001763511","owner_name":"Elsbernd Brian","owner_display_name":"Elsbernd Brian","owner_url":"/insider/0001763511","role":"Officer (Chief Compliance/Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Compliance/Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Compliance/Legal Officer","security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13256.0,"shares_display":"13,256","price_per_share":21.628214544357274,"price_display":"21.63","price_state":"stated","total_value":286703.612,"total_display":"286,703.61","total_whole":"286,704","shares_owned_after":165377.0,"shares_owned_after_display":"165,377","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-26","filed_date":"2024-11-29","scope":"insider","n_lines":2},{"id":2937651,"accession":"0001161697-24-000164","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-24-000164","line_url":"/filing/0001161697-24-000164#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001763511","owner_name":"Elsbernd Brian","owner_display_name":"Elsbernd Brian","owner_url":"/insider/0001763511","role":"Officer (Chief Compliance/Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Compliance/Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Compliance/Legal Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":16.44,"price_display":"16.44","price_state":"stated","total_value":411000.0,"total_display":"411,000.00","total_whole":"411,000","shares_owned_after":124433.0,"shares_owned_after_display":"124,433","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-27","filed_date":"2024-03-28","scope":"insider"},{"id":8742430,"accession":"0001161697-23-000173","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-23-000173","line_url":"/filing/0001161697-23-000173#line-2","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001763511","owner_name":"Elsbernd Brian","owner_display_name":"Elsbernd Brian","owner_url":"/insider/0001763511","role":"Officer (Chief Compliance/Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Compliance/Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Compliance/Legal Officer","security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":16.069,"price_display":"16.07","price_state":"stated","total_value":803450.0,"total_display":"803,450.00","total_whole":"803,450","shares_owned_after":138076.0,"shares_owned_after_display":"138,076","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-20","filed_date":"2023-03-22","scope":"insider"},{"id":6916013,"accession":"0001161697-22-000549","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-22-000549","line_url":"/filing/0001161697-22-000549#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001763511","owner_name":"Elsbernd Brian","owner_display_name":"Elsbernd Brian","owner_url":"/insider/0001763511","role":"Officer (Chief Compliance/Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Compliance/Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Compliance/Legal Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14666.0,"shares_display":"14,666","price_per_share":16.235,"price_display":"16.24","price_state":"stated","total_value":238102.51,"total_display":"238,102.51","total_whole":"238,103","shares_owned_after":11096.0,"shares_owned_after_display":"11,096","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-11","filed_date":"2022-11-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001369568","name":"CATALYST PHARMACEUTICALS, INC.","url":"/issuer/0001369568","role":"Officer (Chief Compliance/Legal Officer)","n_filings":8,"first_seen":"2022-11-15","last_seen":"2025-11-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001763511","retrieved_at":"2026-08-24T10:42:00+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}